Jung Myung-Hwa, Jung Sung-Ju
Department of Aqualife Medicine, Chonnam National University, Republic of Korea.
Department of Aqualife Medicine, Chonnam National University, Republic of Korea.
Fish Shellfish Immunol. 2017 Aug;67:293-301. doi: 10.1016/j.fsi.2017.06.026. Epub 2017 Jun 8.
In this study, we evaluated the potential of poly (I:C) to induce antiviral status for protecting rock bream from RBIV infection. Rock bream injected with poly (I:C) at 2 days before infection (1.1 × 10) at 20 °C had significantly higher protection with RPS 13.4% and 33.4% at 100 and 200 μg/fish, respectively, through 100 days post infection (dpi). The addition of boost immunization with poly (I:C) at before/post infection at 20 °C clearly enhanced the level of protection showing 33.4% and 60.0% at 100 and 200 μg/fish, respectively. To investigate the development of a protective immune response, rock bream were re-infected with RBIV (1.1 × 10) at 200 dpi. While 100% of the previously unexposed fish died, 100% of the previously infected fish survived. Poly (I:C) induced TLR3 and Mx responses were observed at several sampling time points in the spleen, kidney and blood. Moreover, significantly high expression levels of IRF3 (2.9- and 3.1-fold at 1 d and 2 days post administration (dpa), respectively), ISG15 and PKR expression (5.4- and 10.2-fold at 2 dpa, respectively) were observed in the blood, but the expression levels were low in the spleen and kidney after poly (I:C) administration. Our results showed the induction of antiviral immune responses and indicate the possibility of developing long term preventive measures against RBIV using poly (I:C).
在本研究中,我们评估了聚肌胞苷酸(poly (I:C))诱导抗病毒状态以保护条石鲷免受条石鲷虹彩病毒(RBIV)感染的潜力。在20℃下,于感染前2天(1.1×10)注射聚肌胞苷酸的条石鲷,在感染后100天(dpi)时,分别以100和200μg/鱼的剂量,相对保护率(RPS)显著更高,分别为13.4%和33.4%。在20℃下,于感染前/后添加聚肌胞苷酸进行加强免疫,明显提高了保护水平,分别以100和200μg/鱼的剂量时,相对保护率分别为33.4%和60.0%。为了研究保护性免疫反应的发展情况,在200 dpi时用RBIV(1.1×10)对条石鲷进行再次感染。虽然100%先前未接触过病毒的鱼死亡,但100%先前感染过的鱼存活下来。在脾脏、肾脏和血液的几个采样时间点观察到聚肌胞苷酸诱导的Toll样受体3(TLR3)和Mx反应。此外,在血液中观察到干扰素调节因子3(IRF3)的显著高表达水平(给药后1天和2天分别为2.9倍和3.1倍)、ISG15和蛋白激酶R(PKR)的表达(给药后2天分别为5.4倍和10.2倍),但聚肌胞苷酸给药后,脾脏和肾脏中的表达水平较低。我们的结果显示了抗病毒免疫反应的诱导,并表明使用聚肌胞苷酸制定针对RBIV的长期预防措施的可能性。